AFW
BSX icon

Avantra Family Wealth’s Boston Scientific BSX Stock Holding History

Avantra Family Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,569
Closed -$245K – 161
2025
Q4 		$245K Buy
2,569
+32
+1% +$3.14K 0.18% 143
2025
Q3 		$248K Sell
2,537
-71
-3% -$7.35K 0.19% 141
2025
Q2 		$280K Buy
+2,608
New +$264K 0.23% 106

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avantra Family Wealth's BSX Position: Q1 2026 in Review

Avantra Family Wealth sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,569 shares — an estimated $245K sold.

Avantra Family Wealth first reported a position in BSX in Q2 2025 and held it in 3 quarters. The position peaked at $280K in Q2 2025. 1,672 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Avantra Family Wealth reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Avantra Family Wealth sold 2,569 Boston Scientific shares in Q1 2026, an estimated $245K.
  • Avantra Family Wealth first reported a position in Boston Scientific in Q2 2025 and held it in 3 quarters.
  • Avantra Family Wealth's Boston Scientific position peaked at $280K in Q2 2025.
  • 1,672 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Avantra Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.